πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 1,756 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 7429616

Synthesis and complete stereochemical assignment of psymberin/irciniastatin for use as ant

The Board of Regents of the University of Texas System Β· Granted Tue Sep 30 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 25 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7423015

Antihelminthic drugs as a treatment for hyperproliferative diseases

The Board of Regents of the University of Texas System Β· Granted Tue Sep 09 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 04 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7422738

Combined cancer treatment methods using antibodies to aminophospholipids

The Board of Regents of the University of Texas System Β· Granted Tue Sep 09 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 04 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7420100

Methods and compositions relating to HDAC 4 and 5 regulation of cardiac gene expression

The Board of Regents of the University of Texas System Β· Granted Tue Sep 02 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 28 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7420030

Aminopeptidase A (APA) targeting peptides for the treatment of cancer

The Board of Regents of the University of Texas System Β· Granted Tue Sep 02 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 28 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7413781

Gels for encapsulation of biological materials

The Board of Regents of the University of Texas System Β· Granted Tue Aug 19 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 14 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7410950

Peptides of CaV2.2 that inhibit pain

The Board of Regents of the University of Texas System Β· Granted Tue Aug 12 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 07 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7410758

Methods and compositions relating to HPV-associated pre-cancerous and cancerous growths, i

The Board of Regents of the University of Texas System Β· Granted Tue Aug 12 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 07 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7405314

Compounds and methods for the treatment of cancer

The Board of Regents of the University of Texas System Β· Granted Tue Jul 29 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 24 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7405287

Method of treating a cancer

The Board of Regents of the University of Texas System Β· Granted Tue Jul 29 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 24 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7405286

Starsβ€”A muscle-specific actin-binding protein

The Board of Regents of the University of Texas System Β· Granted Tue Jul 29 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 24 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7384909

Anti-viral treatment methods using phosphatidylethanolamine-binding peptides linked to ant

The Board of Regents of the University of Texas System Β· Granted Tue Jun 10 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 05 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7378386

Anti-viral treatment methods using phosphatidylethanolamine-binding peptide derivatives

The Board of Regents of the University of Texas System Β· Granted Tue May 27 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 22 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7371364

Cyclic peptide and imaging compound compositions and uses for targeted imaging and therapy

The Board of Regents of the University of Texas System Β· Granted Tue May 13 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 08 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7368232

High-throughput assay for virus entry and drug screening

The Board of Regents of the University of Texas System Β· Granted Tue May 06 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 01 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7365096

Methods for selectively inhibiting Janus tyrosine kinase 3 (Jak3)

The Board of Regents of the University of Texas System Β· Granted Tue Apr 29 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 24 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7354912

Unique compositions of zwitterionic phospholipids and bisphosphonates and use of the compo

The Board of Regents of the University of Texas System Β· Granted Tue Apr 08 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 03 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7348153

Method for identifying and designing immunogenic peptides

The Board of Regents of the University of Texas System Β· Granted Tue Mar 25 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 20 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7344829

Methods for detecting the efficacy of anticancer treatments

The Board of Regents of the University of Texas System Β· Granted Tue Mar 18 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 13 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7344724

UspA1 and UspA2 antigens of Moraxella catarrhalis

The Board of Regents of the University of Texas System Β· Granted Tue Mar 18 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 13 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7338758

Compositions and methods for the identification, assessment, prevention and therapy of hum

The Board of Regents of the University of Texas System Β· Granted Tue Mar 04 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 28 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7332469

Intrapleural single-chain urokinase alone or complexed to its soluble receptor protects ag

The Board of Regents of the University of Texas System Β· Granted Tue Feb 19 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 14 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7332321

Viral fibers

The Board of Regents of the University of Texas System Β· Granted Tue Feb 19 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 14 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7329642

Ξ²-2-glycoprotein is an inhibitor of angiogenesis

The Board of Regents of the University of Texas System Β· Granted Tue Feb 12 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 07 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted